Antiplatelets versus Anticoagulants for the Treatment of Cervical Artery Dissection: Bayesian Meta-Analysis

Sarikaya, Hakan; Da Costa, Bruno R.; Baumgartner, Ralf; Duclos, Kathleen; Touzé, Emmanuel; de Bray, Jean M; Metso, Antti; Metso, Tiina; Arnold, Marcel; Arauz, Antonio; Zwahlen, Marcel; Jüni, Peter (2013). Antiplatelets versus Anticoagulants for the Treatment of Cervical Artery Dissection: Bayesian Meta-Analysis. PLoS ONE, 8(9), e72697. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0072697

Preview	Text Sarikaya PLoSOne 2013.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (598kB) | Preview
Preview	Image (Corrected table 4) Sarikaya PLoSOne 2013_error correction.cn.tiff - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (272kB) | Preview

OBJECTIVE

To compare the effects of antiplatelets and anticoagulants on stroke and death in patients with acute cervical artery dissection.

DESIGN

Systematic review with Bayesian meta-analysis.

DATA SOURCES

The reviewers searched MEDLINE and EMBASE from inception to November 2012, checked reference lists, and contacted authors.

STUDY SELECTION

Studies were eligible if they were randomised, quasi-randomised or observational comparisons of antiplatelets and anticoagulants in patients with cervical artery dissection.

DATA EXTRACTION

Data were extracted by one reviewer and checked by another. Bayesian techniques were used to appropriately account for studies with scarce event data and imbalances in the size of comparison groups.

DATA SYNTHESIS

Thirty-seven studies (1991 patients) were included. We found no randomised trial. The primary analysis revealed a large treatment effect in favour of antiplatelets for preventing the primary composite outcome of ischaemic stroke, intracranial haemorrhage or death within the first 3 months after treatment initiation (relative risk 0.32, 95% credibility interval 0.12 to 0.63), while the degree of between-study heterogeneity was moderate (τ(2) = 0.18). In an analysis restricted to studies of higher methodological quality, the possible advantage of antiplatelets over anticoagulants was less obvious than in the main analysis (relative risk 0.73, 95% credibility interval 0.17 to 2.30).

CONCLUSION

In view of these results and the safety advantages, easier usage and lower cost of antiplatelets, we conclude that antiplatelets should be given precedence over anticoagulants as a first line treatment in patients with cervical artery dissection unless results of an adequately powered randomised trial suggest the opposite.

Interest & Impact

Downloads

355 since deposited on 28 Nov 2013
28 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item